Long noncoding RNAs in cancer: mechanisms of action and technological advancements.
Bartonicek N, Maag JL, Dinger ME. · 2016
Read Long noncoding RNAs in cancer: mechanisms of action and technological advancements. by Bartonicek N, Maag JL, Dinger ME. (2016) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc4884374.txt.
Description
Nenad Bartonicek, Jesper L. V. Maag, and Marcel E. Dinger reviewed long non-coding RNAs in cancer in Molecular Cancer in 2016. These long RNA strips build no proteins, yet they steer gene use. Their curated count grew by about 10,000 in five years, and the field has moved from listing them in tumors to tracing their roles in core cancer networks.
The review sums up how such RNAs act: guiding gene switches, scaffolding protein groups, and sponging small regulators. Each route maps onto classic cancer traits such as endless growth and spread. New tools to probe their shape and partners get a full survey. Clinic use as markers or drug targets waits on that groundwork.
Catalog record
| CREATOR | Bartonicek N, Maag JL, Dinger ME. |
|---|---|
| YEAR | 2016 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 63 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |